Skip to content

Prospective documentation of inpatient anthroposophic therapy approaches in pediatrics – acute bronchitis

Prospective documentation of inpatient anthroposophic therapy approaches in pediatrics – acute bronchitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00038517
Enrollment
50
Registered
2026-02-04
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J20

Interventions

Group 1: Patients (aged 4 months to 17 years) who are admitted to the study center with acute bronchitis.

Sponsors

Gemeinschaftskrankenhaus Herdecke
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Months to 17 Years

Inclusion criteria

Inclusion criteria: - Diagnosis: Acute bronchitis (ICD J20, J20.0, J20.1, J20.2, J20.3, J20.4, J20.5, J20.6, J20.7, J20.8, J20.9) - Sufficient knowledge of the German language

Exclusion criteria

Exclusion criteria: -Age: =18 years -Lack of German language skills

Design outcomes

Primary

MeasureTime frame
Symptom progression: The presence of symptoms is recorded daily by doctors and parents using predefined questionnaires. Side effects: Doctors document any side effects observed that can be attributed to anthroposophic therapies.

Secondary

MeasureTime frame
Parental satisfaction: Parental satisfaction is recorded using a questionnaire during the hospital stay and 4 weeks after discharge. Estimated effectiveness: Parents (t1: during hospital stay; t2: after 4 weeks) and doctors assess the effectiveness of the therapies in questionnaires. Feasibility: The feasibility of the anthroposophic therapies is recorded by doctors using questionnaires.

Countries

Germany

Contacts

Public ContactTycho Zuzak

Gemeinschaftskrankenhaus Herdecke

t.zuzak@gkh.de0049 2330 62 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026